Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer Journal Article


Authors: Schrump, D. S.; Furukawa, K.; Yamaguchi, H.; Lloyd, K. O.; Old, L. J.
Article Title: Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer
Abstract: Lymph node lymphocytes from patients with primary lung cancer were immortalized with Epstein-Barr virus, and culture supernatants were screened for cell-surface reactivity against allogeneic cancer cell lines. The percentage of wells containing detectable antibodies in initial screening ranged from 1 to 17%, but the vast majority of the cultures lost antibody activity on subsequent expansion. Two antibody-secreting clones, J309 and D579, derived from separate individuals and reactive with anaplastic lung cancer cell lines, were successfully expanded and fused with the NS-1 mouse myeloma cell line. The antibodies produced by these clones exhibited identical restricted serologic reactivity against cultured cell lines and detected a carbohydrate antigen present in the neutral glycolipid fraction of MCF-7 breast cancer cells. Serologic, immunochemical, and chemical analyses revealed that the antigen recognized by antibodies J309 and D579 is galactosylgloboside [Gal(β1→3)GalNAc(β1→3)Gal(α1→4)Gal(β1→4)GlcCer]. Conclusions regarding the significance of these findings with respect to the biology of lung cancer await further information concerning the distribution of galactosylgloboside in normal and malignant tissues and the frequency of antibodies to this structure in normal and tumor-bearing individuals.
Keywords: unclassified drug; lung cancer; tumor antigen; monoclonal antibody; human herpesvirus 4; human; article; mink cell focus-forming virus; galactosylgloboside
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 85
Issue: 12
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 1988-06-01
Start Page: 4441
End Page: 4445
Language: English
DOI: 10.1073/pnas.85.12.4441
PUBMED: 2837767
PROVIDER: scopus
PMCID: PMC280445
DOI/URL:
Notes: Article -- Export Date: 6 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lloyd J Old
    593 Old
  2. Kenneth O Lloyd
    163 Lloyd